المصدر: Zacks Investment Research
وكالة أنباء
الأسهم
أهمية متوسطة
AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure
Amgen beats Q2 earnings and revenue estimates and lifts its 2026 outlook. Key products witness strong growth despite biosimilar pressure on older drugs.
الرموز ذات الصلة
1
A
AMGN
AMGN
المصدر: Zacks Investment Research
زيارة المصدر